As RB1 is infrequently mutated in HPV-negative SCCHN (Figure 4A; [49]), these data suggest that phosphorylation of T356 may serve an important role in functionally inactivating tumor suppression in aggressive disease. The gene discussed is RB1; the disease is head and neck squamous cell carcinoma.